322
Participants
Start Date
August 12, 2021
Primary Completion Date
June 4, 2029
Study Completion Date
June 4, 2029
Belzutifan
Belzutifan, 120 mg, oral, once daily (QD) until progressive disease or discontinuation.
RECRUITING
Semmelweis University-Belgyógyászati és Onkológiai Klinika Hematológia Osztály ( Site 0600), Budapest
RECRUITING
Prince of Wales Hospital-Medical Oncology ( Site 1601), Randwick
RECRUITING
Rigshospitalet ( Site 0304), Copenhagen
RECRUITING
Rigshospitalet-Department of Endocrinology ( Site 0303), Copenhagen
RECRUITING
The Royal Melbourne Hospital ( Site 1602), Parkville
RECRUITING
Odense Universitetshospital ( Site 0302), Odense C
ACTIVE_NOT_RECRUITING
Icahn School of Medicine at Mount Sinai ( Site 0123), New York
RECRUITING
Charité Universitaetsmedizin Berlin - Campus Mitte-Department of Endocrinology and Metabolism ( Site 0503), Berlin
COMPLETED
Institut Paoli-Calmettes-Oncology ( Site 0406), Marseille
RECRUITING
Penn Medicine: University of Pennsylvania Health System-Heme/Onc ( Site 0127), Philadelphia
COMPLETED
Ospedale San Raffaele-Oncologia Medica ( Site 0705), Milan
RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori-S.C. Oncologia Medica 2- Sarcomi ( Site 0709), Milan
RECRUITING
Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Medica Gastrointestinale e Tumori Neuroe ( Site 0700), Milan
RECRUITING
National Institutes of Health ( Site 0125), Bethesda
RECRUITING
Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - Developmental Therapeutics ( Site 0108), Baltimore
RECRUITING
Azienda Ospedaliera Spedali Civili di Brescia-Oncology ( Site 0701), Brescia
COMPLETED
MD Anderson Cancer Center-Oncology ( Site 1102), Madrid
ACTIVE_NOT_RECRUITING
Hospital Universitario 12 de Octubre-Medical Oncology ( Site 1103), Madrid
RECRUITING
Hospital Universitario Central de Asturias-Medical Oncology ( Site 1101), Oviedo
COMPLETED
Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 0902), Istanbul
RECRUITING
Ege University Medicine of Faculty ( Site 0900), Bornova
RECRUITING
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Roma ( Site 0703), Verona
RECRUITING
SCRI Oncology Partners ( Site 7000), Nashville
RECRUITING
Vanderbilt University Medical Center ( Site 0107), Nashville
RECRUITING
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 0708), Bologna
RECRUITING
Universitaetsklinikum Duesseldorf-Gastroenterology, Hepatology and Infectiology ( Site 0505), Düsseldorf
RECRUITING
University of Michigan ( Site 0126), Ann Arbor
RECRUITING
University of Iowa ( Site 0104), Iowa City
RECRUITING
Azienda Ospedaliero Universitaria Senese-U.O.C. Immunoterapia Oncologica ( Site 0706), Siena
RECRUITING
Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130), Chicago
ACTIVE_NOT_RECRUITING
Washington University-Internal Medicine/Oncology ( Site 0124), St Louis
RECRUITING
CHU Strasbourg-Hautepierre-Medecine Interne, Endocrinologie et Nutrition ( Site 0402), Strasbourg
RECRUITING
Hôpital Edouard Herriot-oncologie ( Site 0405), Lyon
RECRUITING
Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 0404), Paris
RECRUITING
University of Texas MD Anderson Cancer Center ( Site 0112), Houston
RECRUITING
Universitaetsklinikum Freiburg ( Site 0504), Freiburg
COMPLETED
University of Naples Federico II-Dipartimento di Medicina Clinica e Chirurgia ( Site 0704), Naples
COMPLETED
Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Department of Internal Medicine IV, Division ( Site 0501), München
RECRUITING
Cedars-Sinai Medical Center ( Site 0110), Los Angeles
RECRUITING
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre ( Site 0407), Le Kremlin-Bicêtre
RECRUITING
Gustave Roussy ( Site 0403), Villejuif
RECRUITING
Comprehensive Cancer Center Mainfranken-Div. of Endocrinology and Diabetes ( Site 0500), Würzburg
ACTIVE_NOT_RECRUITING
Peking University First Hospital-Urology ( Site 1900), Beijing
RECRUITING
Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF ( Site 0801), Moscow
COMPLETED
Endocrinology Research Center of Rosmedtechnologies-Surgery ( Site 0809), Moscow
RECRUITING
National Cancer Centre Singapore ( Site 1700), Singapore
COMPLETED
Saint Petersburg State University-Clinic of advanced medical technologies n. a. Nicolay I. Pirogov ( Site 0805), Saint Petersburg
RECRUITING
Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 0803), Saint Petersburg
ACTIVE_NOT_RECRUITING
Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1904), Shanghai
RECRUITING
GBUZ Republican Clinical Oncological Dispensary ( Site 0804), Ufa
RECRUITING
Sun Yat-sen University Cancer Center ( Site 1905), Guangzhou
COMPLETED
West China Hospital of Sichuan University ( Site 1906), Chengdu
RECRUITING
Sheba Medical Center-Institute of Endocrinology, Diabetes and Metabolism ( Site 1400), Ramat Gan
RECRUITING
Sourasky Medical Center ( Site 1401), Tel Aviv
RECRUITING
FALP ( Site 2200), Santiago
RECRUITING
Centro de Oncología de Precisión ( Site 2203), Santiago
RECRUITING
Massachusetts General Hospital ( Site 0111), Boston
RECRUITING
Arthur J.E. Child Comprehensive Cancer Centre ( Site 0203), Calgary
RECRUITING
Princess Margaret Cancer Centre ( Site 0202), Toronto
ACTIVE_NOT_RECRUITING
Hokkaido University Hospital ( Site 1800), Sapporo
ACTIVE_NOT_RECRUITING
Yokohama City University Hospital ( Site 1804), Yokohama
ACTIVE_NOT_RECRUITING
Kochi Medical School Hospital ( Site 1807), Nankoku
ACTIVE_NOT_RECRUITING
National Cancer Center Hospital ( Site 1802), Chuo-ku
ACTIVE_NOT_RECRUITING
Kyoto University Hospital ( Site 1806), Kyoto
ACTIVE_NOT_RECRUITING
Tokyo Women's Medical University Adachi Medical Center ( Site 1803), Tokyo
RECRUITING
Universitair Medisch Centrum Utrecht ( Site 1530), Utrecht
RECRUITING
Oslo Universitetssykehus Radiumhospitalet ( Site 2400), Oslo
RECRUITING
START Lisbon - Hospital de Santa Maria ( Site 2601), Lisbon
RECRUITING
Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E. ( Site 2600), Porto
RECRUITING
Seoul National University Hospital ( Site 2001), Jongno-gu
RECRUITING
Asan Medical Center ( Site 2000), Songpa-gu
RECRUITING
Hospital Universitari Vall d'Hebron ( Site 1100), Barcelona
RECRUITING
Skanes University Hospital Lund ( Site 1200), Lund
COMPLETED
Karolinska Universitetssjukhuset Solna ( Site 1202), Stockholm
RECRUITING
Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1201), Uppsala
RECRUITING
Sahlgrenska Universitetssjukhuset-Department of Oncology CTU Clinical Trial Unit ( Site 1204), Gothenburg
RECRUITING
Baskent University Adana Training Hospital ( Site 0906), Yüreğir
RECRUITING
Hacettepe Universitesi-oncology hospital ( Site 0901), Ankara
RECRUITING
Ankara Bilkent Şehir Hastanesi. ( Site 0904), Ankara
RECRUITING
Addenbrooke's Hospital ( Site 1309), Cambridge
COMPLETED
Royal Free Hospital ( Site 1302), London
RECRUITING
The Beatson West of Scotland Cancer Centre ( Site 1308), Glasgow
RECRUITING
Hammersmith Hospital-Medical Oncology ( Site 1304), London
Merck Sharp & Dohme LLC
INDUSTRY